Skip to content
10-Q

Quarterly Report

Infinity Pharmaceuticals, Inc.

0001113148-22-000022

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 7, 2022 89.35M sh
Shares Diluted Q3 2022 · Sep 30, 2022 89.39M sh
Shares Diluted Q3 2022 · Sep 30, 2022 89.21M sh
Shares Diluted Q3 2022 · Sep 30, 2021 88.77M sh
Shares Diluted Q3 2022 · Sep 30, 2021 84.43M sh
Capex Q3 2022 · Sep 30, 2022 $17K
Capex Q3 2022 · Sep 30, 2021 $11K
Operating Cash Flow Q3 2022 · Sep 30, 2022 −$33.53M
Operating Cash Flow Q3 2022 · Sep 30, 2021 −$30.9M
Cash And Equivalents Q3 2022 · Sep 30, 2022 $47.18M
Cash And Equivalents Q3 2022 · Dec 31, 2021 $80.73M
Cash And Equivalents Q3 2022 · Sep 30, 2021 $90.09M
Stockholders Equity Q3 2022 · Sep 30, 2022 −$10.87M
Stockholders Equity Q3 2022 · Jun 30, 2022 −$1.11M
Stockholders Equity Q3 2022 · Dec 31, 2021 $21.57M
Stockholders Equity Q3 2022 · Sep 30, 2021 $32.14M
Stockholders Equity Q3 2022 · Jun 30, 2021 $41.54M
Stockholders Equity Q3 2022 · Dec 31, 2020 −$22.99M
Current Liabilities Q3 2022 · Sep 30, 2022 $14.2M
Current Liabilities Q3 2022 · Dec 31, 2021 $13.3M
Total Liabilities Q3 2022 · Sep 30, 2022 $62.47M
Total Liabilities Q3 2022 · Dec 31, 2021 $63.21M
Current Assets Q3 2022 · Sep 30, 2022 $49.35M
Current Assets Q3 2022 · Dec 31, 2021 $82.27M
Total Assets Q3 2022 · Sep 30, 2022 $51.59M
Total Assets Q3 2022 · Dec 31, 2021 $84.79M
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.12
Eps Diluted Q3 2022 · Sep 30, 2022 −$0.39
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.12
Eps Diluted Q3 2022 · Sep 30, 2021 −$0.40
Eps Basic Q3 2022 · Sep 30, 2022 −$0.12
Eps Basic Q3 2022 · Sep 30, 2022 −$0.39
Eps Basic Q3 2022 · Sep 30, 2021 −$0.12
Eps Basic Q3 2022 · Sep 30, 2021 −$0.40
Sga Expense Q3 2022 · Sep 30, 2022 $3.5M
Sga Expense Q3 2022 · Sep 30, 2022 $10.67M
Sga Expense Q3 2022 · Sep 30, 2021 $3.85M
Sga Expense Q3 2022 · Sep 30, 2021 $10.91M
Rd Expense Q3 2022 · Sep 30, 2022 $7.66M
Rd Expense Q3 2022 · Sep 30, 2022 $25.45M
Rd Expense Q3 2022 · Sep 30, 2021 $7.07M
Rd Expense Q3 2022 · Sep 30, 2021 $23.23M
Net Income Q3 2022 · Sep 30, 2022 −$10.72M
Net Income Q3 2022 · Sep 30, 2022 −$35.14M
Net Income Q3 2022 · Sep 30, 2021 −$10.71M
Net Income Q3 2022 · Sep 30, 2021 −$33.61M
Operating Income Q3 2022 · Sep 30, 2022 −$10.88M
Operating Income Q3 2022 · Sep 30, 2022 −$35.31M
Operating Income Q3 2022 · Sep 30, 2021 −$10.75M
Operating Income Q3 2022 · Sep 30, 2021 −$33.58M
Revenue Q3 2022 · Sep 30, 2022 $712K
Revenue Q3 2022 · Sep 30, 2022 $2.05M
Revenue Q3 2022 · Sep 30, 2021 $428K
Revenue Q3 2022 · Sep 30, 2021 $1.41M